These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 6158722)
1. Eye disease drug as a potential cure for COVID-19: one foot-in-the-door. Patel P Eye (Lond); 2023 Oct; 37(14):2844-2846. PubMed ID: 36813997 [No Abstract] [Full Text] [Related]
2. [Papain electrophoresis in treatment of eye diseases]. Starkov GL; Abramova IN Oftalmol Zh; 1975; 30(6):450-3. PubMed ID: 1228526 [No Abstract] [Full Text] [Related]
3. [Rationale for using rheopolyglucin electrophoresis in eye diseases]. Pil'ganchuk VV Vestn Oftalmol; 1987; 103(3):59-62. PubMed ID: 2442877 [No Abstract] [Full Text] [Related]
4. [Effectiveness of novocaine diadynamophoresis in the treatment of postoperative pain after lung surgery]. Sokolov SB; Korchagin AB; Leshchinskaia NP Vopr Kurortol Fizioter Lech Fiz Kult; 1976; (4):61-3. PubMed ID: 1014438 [No Abstract] [Full Text] [Related]
5. [Drug electrophoresis in the overall treatment of the eye lesions in endocrine diseases]. Danilova AI Oftalmol Zh; 1980; 35(5):268-72. PubMed ID: 7422212 [No Abstract] [Full Text] [Related]
6. [Iontophoresis of calcium and adrenaline in treatment of inflammatory conditions of the eyes]. Mika T; Szymankowa G; Lisowski Z; Merz M Klin Oczna; 1968; 38(3):497-502. PubMed ID: 5668389 [No Abstract] [Full Text] [Related]
7. [Drug diadynamophoresis in the overall treatment of eye diseases]. Khriapchenkova MP; Ladniuk TA Oftalmol Zh; 1980; 35(5):275-8. PubMed ID: 6158722 [No Abstract] [Full Text] [Related]
8. Iontophoresis: a non-invasive ocular drug delivery. Eljarrat-Binstock E; Domb AJ J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678 [TBL] [Abstract][Full Text] [Related]
9. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Myles ME; Neumann DM; Hill JM Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884 [TBL] [Abstract][Full Text] [Related]
10. [Iontophoresis: past and future]. Behar-Cohen F; El Aouni A; Le Rouic JF; Parel JM; Renard G; Chauvaud D J Fr Ophtalmol; 2001 Mar; 24(3):319-27. PubMed ID: 11285450 [No Abstract] [Full Text] [Related]
11. Ophthalmic drug delivery: development and regulatory considerations. Novack GD Clin Pharmacol Ther; 2009 May; 85(5):539-43. PubMed ID: 19225448 [No Abstract] [Full Text] [Related]
12. [The use of magnetic fields in ophthalmology]. Skrinnik AV; Moiseeva NN Oftalmol Zh; 1990; (8):492-6. PubMed ID: 2095478 [No Abstract] [Full Text] [Related]